Anebulo Pharmaceuticals Inc (ANEB) Stock Price

2.54 ▲ +0.01 (+0.40%)
Open: 2.44 Vol: 17.54K Day's range: 2.44 - 2.54 Nov 05, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ANEB Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 2.52▼ 2.52▼ 2.53▼ 2.58▼ 2.58▼
MA10 2.54▼ 2.54▼ 2.58▼ 2.65▼ 2.49▲
MA20 2.59▼ 2.61▼ 2.64▼ 2.60▼ 2.37▲
MA50 2.66▼ 2.60▼ 2.56▼ 2.48▲ 1.73▲
MA100 2.57▼ 2.50▼ 2.50▲ 2.32▲ 2.04▲
MA200 2.50▲ 2.47▲ 2.56▼ 1.78▲ 2.73▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.006▼ -0.016▼ -0.027▼ -0.023▼ -0.004▼
RSI 31.394▼ 33.256▼ 35.833▼ 48.103▼ 57.911▲
STOCH 32.222     28.919     24.425     31.733     68.970    
WILL %R -86.667▼ -91.304▼ -91.304▼ -75.610▼ -31.852    
CCI -119.543▼ -93.741     -106.207▼ -143.824▼ 32.355    
Latest Filters Detected On ANEB
▼ GAP $ANEB Open Gap Down %3 Set Alert
▼ GAP $ANEB Open Gap Down %2 Set Alert
CDL $ANEB Marubozu Candlestick Pattern Detected Set Alert
Anebulo Pharmaceuticals Inc News
NYSE owner dives into prediction markets with $2 billion Polymarket investment
Thursday, October 09, 2025 06:03 PM
Intercontinental Exchange Inc. is making a big move into the fast-growing realm of prediction markets, as the owner of the iconic New York Stock Exchange looks to keep pace with its rivals. The $2 ...
Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Recent Updates
Sunday, September 28, 2025 05:00 PM
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company” or ...
Anebulo Pharmaceuticals Announces First Patients Dosed in Phase 1 Single Ascending Dose Study of Intravenous Selonabant, under Development for Acute Cannabis-Induced Toxicity
Thursday, September 25, 2025 12:30 AM
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid-induced toxicities (the “Company” or ...
ANEB historical stock data
date open high low close volume
05/11/25 2.44 2.54 2.44 2.54 17,539
04/11/25 2.53 2.56 2.48 2.53 22,197
03/11/25 2.59 2.65 2.54 2.54 25,103
31/10/25 2.54 2.64 2.51 2.64 10,605
30/10/25 2.58 2.65 2.58 2.64 6,440
29/10/25 2.705 2.72 2.6202 2.71 6,959
28/10/25 2.68 2.7499 2.66 2.69 9,601
27/10/25 2.76 2.76 2.66 2.70 8,903
24/10/25 2.7275 2.75 2.71 2.75 9,391
23/10/25 2.74 2.77 2.71 2.72 30,203
Quote Details
52wk Low:0.80
52wk High:3.42
Vol:17.54K
Avg Vol(3m):1M
1Y Chng:+67.11%
1M Chng:+4.10%
Add to Watch List
More Information
Index US Composite
Market Cap. 103.94M